Associate Professor Katherine Gibney, MBBS, MPH, FRACP, FAFPHD, PhD
Australia

Associate Professor Katherine Gibney, MBBS, MPH, FRACP, FAFPHD, PhD

Controversies in antibiotic prophylaxis for household contacts of Invasive Group A Streptococcal patients

Biography

APPOINTMENTS Current: Principal Research Fellow, Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Australia Deputy Director, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Australia Co-chair, Australian Technical Advisory Group on Immunisation (ATAGI) Past—Clinical medicine: Infectious Diseases Physician, 2016–2020. Austin Hospital / Eastern Health Hospitals, Melbourne, Australia Infectious Diseases Registrar, 2006–2009. Royal Darwin / Royal Melbourne / Royal Children’s Hospitals Intern & Resident, 2004–05. Royal Darwin / Tennant Creek / Alice Springs Hospitals Past—Other: Public Health Physician / Epidemiologist, 2012–2024. Victorian Department of Health Research Fellow, 2011–2016. Department of Epidemiology and Preventive Medicine, Monash University Epidemic Intelligence Service (EIS) Fellow, 2009–2011. US Centers for Disease Control & Prevention (CDC) AWARDS 2024 & 2025 Finalist, Eureka Prize for Infectious Diseases Research 2023 University of Melbourne Award for Excellence in Interdisciplinary Research 2021 Dean’s Award for outstanding service, Faculty Medicine, Dentistry and Health Sciences, Uni Melb 2017 Premier’s Award for Health and Medical Research, Commendation ACADEMIC RECORD AND QUALIFICATIONS 2016 Doctor of Philosophy – Surveillance and burden of infectious diseases in Australia, Monash Uni 2015 Fellow of the Australasian Faculty of Public Health Medicine (FAFPHM) 2011 Epidemic Intelligence Service (EIS) – US Centers for Disease Control & Prevention (CDC) 2010 Fellow of the Royal Australasian College of Physicians (FRACP, Infectious Diseases) ACADEMIC AND RESEARCH LEADERSHIP Research group lead, Department of Infectious Diseases, UniMelb, primarily focused on Strep A disease Co-ordinating principal investigator on two randomised controlled trials in invasive group A strep (iGAS), funded by MRFF (CIA, MRF2035666) and NHMRC (CIA, GNT2032163 ) Co-lead, Public Health Cross Cutting Discipline, Doherty Institute, UniMelb Executive Committee Member, Department of Infectious Diseases, UniMelb [2025–ongoing] Doherty lead, COVID-19 Victorian Consortium—Clinical and Public Health Pillar funded by Victorian Department of Health; Optimise Study co-lead with Prof Margaret Hellard (Burnet Institute) CURRENT RESEARCH GRANTS MRFF Clinical Trials Activity (MRF2035666), 2025–2030, $4,990,959 (CIA) NHMRC Clinical Trials and Cohort Studies (GNT2032163), 2024–2029, $3,960,000 (CIA) MRFF Post-Acute Sequalae of COVID-19 (MRF2034238), 2024–2025, $250,000 (CI) NHMRC/MRFF Investigator Grant (MRF1193727) 2021–2025, $1,449,800 (CIA)